Home › Calculator › GNNSF Dividend Calculator 2026
GNNSF Dividend DRIP Calculator 2026
50.00% YieldHealthcareGenscript Biotech Corporation · OTC
Price: $4.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GNNSF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your GNNSF snowball 📈
$10,000 in GNNSF → $16.27M in 10 years · $661.64/month
About Genscript Biotech Corporation (GNNSF) — Dividend Analysis 2026
Genscript Biotech Corporation, an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan, other Asia Pacific regions, and beyond. The company is structured into four distinct business units. Its Life Science Services and Products division delivers essential research support, encompassing gene synthesis, molecular cloning, oligonucleotide and peptide synthesis, protein engineering, antibody development, and the creation of molecular diagnostic tools and genome editing materials. These offerings cater to diverse fields such as fundamental biological research, pharmaceutical development, drug discovery, disease diagnostics, vaccine production, agriculture, environmental research, and the food sector. The Biologics Development Services segment provides comprehensive support for drug development, assisting pharmaceutical, biotechnology, government, and academic organizations. This includes antibody drug discovery, preclinical and clinical development of antibody therapeutics, and the preclinical and clinical advancement of plasmids and viruses for gene and cell therapies. Within its Industrial Synthetic Biology Products segment, the company specializes in engineering non-pathogenic microbial strains and manufacturing industrial enzymes. These are applied across various industries, including food processing, animal feed, pharmaceuticals, and chemicals. Finally, the Cell Therapy division is dedicated to the discovery and development of chimeric antigen receptor T-cell (CAR T-cell) therapies specifically for treating both liquid and solid tumors. Established in 2002, Genscript Biotech Corporation is headquartered in Nanjing, People's Republic of China.
Compare GNNSF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GNNSF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GNNSF position with:
🌍 GNNSF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GNNSF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 50.00% | 47.20% | $5,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 42.50% | 39.70% | $4,250 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 40.00% | 37.20% | $4,000 / yr |
| 🇬🇧 UK ISA | 0% | 50.00% | 47.20% | $5,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 45.63% | 42.83% | $4,563 / yr |
| 🇨🇦 TFSA | 0% | 50.00% | 47.20% | $5,000 / yr |
| 🇨🇦 CA Taxable | 25% | 37.50% | 34.70% | $3,750 / yr |
| 🇦🇺 Super (pension) | 15% | 42.50% | 39.70% | $4,250 / yr |
| 🇦🇺 AU Taxable | 30% | 35.00% | 32.20% | $3,500 / yr |
| 🇩🇪 DE Taxable | 26.375% | 36.81% | 34.01% | $3,681 / yr |
| 🇫🇷 FR Taxable | 30% | 35.00% | 32.20% | $3,500 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GNNSF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GNNSF Dividend Payment Schedule
GNNSF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 GNNSF vs Healthcare Benchmarks
How GNNSF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GNNSF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GNNSF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GNNSF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Genscript Biotech Corporation (GNNSF) is currently trading at $4.00, 22% below its 52-week high. The current dividend yield is 50.00% based on an annual payout of $2.00 per share.
GNNSF (Genscript Biotech Corporation) — 50.00% Dividend Yield Analysis
Genscript Biotech Corporation (GNNSF) is a healthcare stock currently trading at $4.00 with a dividend yield of 50.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (50.00%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.